Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?
about
What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classificationFIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication.Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute.Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancerImprovements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture.Clinical features and outcomes of neck lymphatic metastasis in ovarian epithelial carcinoma.Ovarian cancer initially presenting with isolated ipsilateral superficial inguinal lymph node metastasis: a case study and review of the literature.Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patients.Clinical impact of systematic pelvic and para-aortic lymphadenectomy for pT1 and pT2 ovarian cancer: a retrospective survey by the Sankai Gynecology Study Group.Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
P2860
Q31143363-42CEFD47-DEA1-4006-BEE9-FBEB20FB0523Q33392472-8A795509-77F8-463D-B156-91101D66526EQ33457920-E82372A5-7A6A-4309-AE2F-31086C30CC4EQ35198222-12F7D796-A6E5-4A75-8644-73344246BBF4Q35419216-10E50E92-B732-483E-989B-B87D94AE6BDFQ35692182-E1D06EF6-718C-4C49-AE5C-45C7861E7A73Q37177699-E468E1A8-CE60-496E-B19F-CDC6CD3D2338Q37249307-74B23467-76A7-41E8-A854-954148779890Q37363520-EA746B0B-312B-46B4-BDE0-B08060FE835CQ37588831-2282B370-2728-46EB-A321-11E429806FFBQ38676869-5A4ED5A5-366C-4737-9AD3-33A7A41D1D4CQ39793145-B251D363-9137-4849-A294-C0ABD3EBE8EBQ45698817-E10D1211-1976-4949-8F09-F7EABE6B2096Q47361459-CBB40646-6CC9-4A8C-813A-C2D2D16AE297Q52728811-AED6A663-8307-45CB-9A43-FD3E8175FDBB
P2860
Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Is it justified to classify pa ...... sed on nodal involvement only?
@en
Is it justified to classify pa ...... sed on nodal involvement only?
@nl
type
label
Is it justified to classify pa ...... sed on nodal involvement only?
@en
Is it justified to classify pa ...... sed on nodal involvement only?
@nl
prefLabel
Is it justified to classify pa ...... sed on nodal involvement only?
@en
Is it justified to classify pa ...... sed on nodal involvement only?
@nl
P2093
P1433
P1476
Is it justified to classify pa ...... sed on nodal involvement only?
@en
P2093
Karl C Podratz
Timothy O Wilson
William A Cliby
P304
P356
10.1016/J.YGYNO.2006.08.047
P407
P577
2006-10-18T00:00:00Z